KDM3A and Ewing sarcoma: Since, miR-22 was reported to target and regulate KDM3A in Ewing sarcoma [43], these findings suggest that miR-22 may regulate both PHF8 and KDM3A in LNCaP cells, at steady state as well as in the presence of CS-FBS or IL-6.